Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté

Dernières actualités du secteur


Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34

Turning plastic into medicine: Closing the loop on pharma production

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol. The post Turning plastic into medicine: Closing the loop on pharma...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Special Episode: The 2025 BIO International Convention

In this week’s episode we meet three innovators on the floor in Boston and find out what their BIO experience has been like The post Special Episode: The 2025 BIO International Convention appeared...

www.labiotech.eu
Nouvelle réponse - Il y a 4 jours

Quel est le protocole pour un test de dépistage d'hypersensibilité alimentaire et combien d'aliments peuvent y être inclus?

FranceBiotechnologies
à répondu :

Pour réaliser un test de dépistage d'hypersensibilité alimentaire, une approche basée sur la qPCR ou la PCR digitale est recommandée. Lire plus

Image Kits d'Analyse Alimentaire Kits d'Analyse Alimentaire
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 6 jours

From undruggable to oral therapy: The rise of STAT6 degraders

Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment. The post From undruggable to oral therapy: The rise of STAT6 degraders appeared first...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

Six kidney disease companies you should know about in 2025

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives. The post Six kidney disease companies you should know about in...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

Did Novo open the Canadian market to GLP-1 generics?

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee? The post Did Novo open the Canadian market to GLP-1 generics?...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech

In this episode Alex Telford, co-founder of Convoke, explains the work he is doing before opening the door to his insatiable curiosity about the biotech industry. The post Alex Telford on AI, drug...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

A new era in migraine treatment: Innovative drugs redefining the field

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better. The post A new era in migraine treatment: Innovative drugs...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

Can gene therapy treat vision loss?

Since the approval of Luxturna, there has been a wave of companies developing treatments with the potential to cure different forms of genetic blindness. The post Can gene therapy treat vision loss?...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 1 semaine

Behind the Cure51 deal: Is NVIDIA becoming biotech’s AI infrastructure?

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the industry. The post Behind the Cure51 deal: Is NVIDIA becoming biotech’s...

www.labiotech.eu
Charger plus d'actualités